TOKYO -- Takeda Pharmaceutical is offering early retirement to sales staff and other workers in Japan as the drugmaker strategically narrows its focus areas and slims down its workforce.
With a worldwide workforce of about 47,500, Takeda employs 5,350 in Japan, including roughly 2,100 medical representatives. It has been working on restructuring since its January 2019 megadeal to acquire Irish biotech Shire and is moving to specialize in five key business areas, such as oncology and rare diseases.
